vs
FiscalNote Holdings, Inc.（NOTE）与Sight Sciences, Inc.（SGHT）财务数据对比。点击上方公司名可切换其他公司
FiscalNote Holdings, Inc.的季度营收约是Sight Sciences, Inc.的1.1倍（$22.2M vs $20.4M），Sight Sciences, Inc.同比增速更快（6.9% vs -24.7%），FiscalNote Holdings, Inc.自由现金流更多（$-1.9M vs $-2.0M），过去两年Sight Sciences, Inc.的营收复合增速更高（2.9% vs -16.8%）
FiscalNote Holdings, Inc.（常称FiscalNote）是一家上市的软件数据与传媒企业，总部位于美国华盛顿特区，2013年由三位创始人创立。核心业务为通过政府关系管理服务FiscalNote GRM提供软件工具、平台、数据服务与资讯，同时依托人工智能平台分析美国待审议法案相关内容。
Sight Sciences, Inc.是一家处于商业化阶段的医疗科技企业，专注于开发及商业化青光眼、干眼症等常见眼部疾病的创新治疗产品，提供微创手术设备与非手术护理解决方案，主要服务美国市场的眼科医师及患者。
NOTE vs SGHT — 直观对比
营收规模更大
NOTE
是对方的1.1倍
$20.4M
营收增速更快
SGHT
高出31.5%
-24.7%
自由现金流更多
NOTE
多$62.0K
$-2.0M
两年增速更快
SGHT
近两年复合增速
-16.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $22.2M | $20.4M |
| 净利润 | — | $-4.2M |
| 毛利率 | — | 87.3% |
| 营业利润率 | -83.7% | -18.0% |
| 净利率 | — | -20.4% |
| 营收同比 | -24.7% | 6.9% |
| 净利润同比 | — | 64.9% |
| 每股收益（稀释后） | $-2.81 | $-0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NOTESGHT
| Q4 25 | $22.2M | $20.4M | ||
| Q3 25 | $22.4M | $19.9M | ||
| Q2 25 | $23.3M | $19.6M | ||
| Q1 25 | $27.5M | $17.5M | ||
| Q4 24 | $29.5M | $19.1M | ||
| Q3 24 | $29.4M | $20.2M | ||
| Q2 24 | $29.2M | $21.4M | ||
| Q1 24 | $32.1M | $19.3M |
净利润NOTESGHT
| Q4 25 | — | $-4.2M | ||
| Q3 25 | $-24.9M | $-8.2M | ||
| Q2 25 | $-13.3M | $-11.9M | ||
| Q1 25 | $-4.3M | $-14.2M | ||
| Q4 24 | — | $-11.8M | ||
| Q3 24 | $-14.9M | $-11.1M | ||
| Q2 24 | $-12.8M | $-12.3M | ||
| Q1 24 | $50.6M | $-16.3M |
毛利率NOTESGHT
| Q4 25 | — | 87.3% | ||
| Q3 25 | — | 86.4% | ||
| Q2 25 | — | 84.8% | ||
| Q1 25 | — | 86.2% | ||
| Q4 24 | — | 86.8% | ||
| Q3 24 | — | 83.9% | ||
| Q2 24 | — | 85.8% | ||
| Q1 24 | — | 85.5% |
营业利润率NOTESGHT
| Q4 25 | -83.7% | -18.0% | ||
| Q3 25 | -43.4% | -39.7% | ||
| Q2 25 | -31.9% | -59.6% | ||
| Q1 25 | -50.0% | -79.2% | ||
| Q4 24 | -19.4% | -62.5% | ||
| Q3 24 | -23.1% | -55.7% | ||
| Q2 24 | -27.2% | -59.2% | ||
| Q1 24 | -35.6% | -76.4% |
净利率NOTESGHT
| Q4 25 | — | -20.4% | ||
| Q3 25 | -110.8% | -41.0% | ||
| Q2 25 | -57.0% | -61.0% | ||
| Q1 25 | -15.4% | -80.8% | ||
| Q4 24 | — | -62.1% | ||
| Q3 24 | -50.7% | -54.9% | ||
| Q2 24 | -43.6% | -57.7% | ||
| Q1 24 | 157.6% | -84.4% |
每股收益（稀释后）NOTESGHT
| Q4 25 | $-2.81 | $-0.07 | ||
| Q3 25 | $-1.73 | $-0.16 | ||
| Q2 25 | $-0.08 | $-0.23 | ||
| Q1 25 | $-0.03 | $-0.28 | ||
| Q4 24 | $1.88 | $-0.23 | ||
| Q3 24 | $-1.33 | $-0.22 | ||
| Q2 24 | $-0.09 | $-0.25 | ||
| Q1 24 | $0.37 | $-0.33 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $26.3M | $92.0M |
| 总债务越低越好 | $128.4M | $42.4M |
| 股东权益账面价值 | $62.0M | $63.9M |
| 总资产 | $255.1M | $115.3M |
| 负债/权益比越低杠杆越低 | 2.07× | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资NOTESGHT
| Q4 25 | $26.3M | $92.0M | ||
| Q3 25 | $31.2M | $92.4M | ||
| Q2 25 | $38.5M | $101.5M | ||
| Q1 25 | $46.3M | $108.8M | ||
| Q4 24 | $34.6M | $120.4M | ||
| Q3 24 | $32.7M | $118.6M | ||
| Q2 24 | $37.7M | $118.2M | ||
| Q1 24 | $43.6M | $127.3M |
总债务NOTESGHT
| Q4 25 | $128.4M | $42.4M | ||
| Q3 25 | $131.5M | $42.4M | ||
| Q2 25 | $116.7M | $42.4M | ||
| Q1 25 | $118.0M | $42.4M | ||
| Q4 24 | $147.1M | $40.0M | ||
| Q3 24 | $152.2M | $37.1M | ||
| Q2 24 | $145.9M | $35.0M | ||
| Q1 24 | $153.0M | $35.0M |
股东权益NOTESGHT
| Q4 25 | $62.0M | $63.9M | ||
| Q3 25 | $75.5M | $64.3M | ||
| Q2 25 | $95.1M | $70.0M | ||
| Q1 25 | $98.7M | $77.6M | ||
| Q4 24 | $97.8M | $87.5M | ||
| Q3 24 | $98.5M | $95.0M | ||
| Q2 24 | $106.9M | $101.6M | ||
| Q1 24 | $106.1M | $109.2M |
总资产NOTESGHT
| Q4 25 | $255.1M | $115.3M | ||
| Q3 25 | $273.9M | $116.3M | ||
| Q2 25 | $288.3M | $122.0M | ||
| Q1 25 | $299.7M | $129.7M | ||
| Q4 24 | $326.2M | $142.8M | ||
| Q3 24 | $337.9M | $143.6M | ||
| Q2 24 | $346.3M | $149.7M | ||
| Q1 24 | $357.8M | $155.6M |
负债/权益比NOTESGHT
| Q4 25 | 2.07× | 0.66× | ||
| Q3 25 | 1.74× | 0.66× | ||
| Q2 25 | 1.23× | 0.61× | ||
| Q1 25 | 1.20× | 0.55× | ||
| Q4 24 | 1.50× | 0.46× | ||
| Q3 24 | 1.54× | 0.39× | ||
| Q2 24 | 1.36× | 0.34× | ||
| Q1 24 | 1.44× | 0.32× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-279.0K | $-1.8M |
| 自由现金流经营现金流 - 资本支出 | $-1.9M | $-2.0M |
| 自由现金流率自由现金流/营收 | -8.7% | -9.7% |
| 资本支出强度资本支出/营收 | 7.4% | 0.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-18.6M | — |
8季度趋势，按日历期对齐
经营现金流NOTESGHT
| Q4 25 | $-279.0K | $-1.8M | ||
| Q3 25 | $-8.3M | $-8.7M | ||
| Q2 25 | $-6.2M | $-7.5M | ||
| Q1 25 | $3.3M | $-11.6M | ||
| Q4 24 | $-1.3M | $-3.5M | ||
| Q3 24 | $-3.0M | $362.0K | ||
| Q2 24 | $-3.7M | $-9.5M | ||
| Q1 24 | $2.7M | $-9.8M |
自由现金流NOTESGHT
| Q4 25 | $-1.9M | $-2.0M | ||
| Q3 25 | $-10.4M | $-8.9M | ||
| Q2 25 | $-7.7M | $-7.8M | ||
| Q1 25 | $1.3M | — | ||
| Q4 24 | $-3.4M | $-3.6M | ||
| Q3 24 | $-5.4M | $311.0K | ||
| Q2 24 | $-6.5M | $-9.5M | ||
| Q1 24 | $1.0M | $-9.9M |
自由现金流率NOTESGHT
| Q4 25 | -8.7% | -9.7% | ||
| Q3 25 | -46.2% | -44.7% | ||
| Q2 25 | -33.0% | -39.6% | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | -11.4% | -18.9% | ||
| Q3 24 | -18.4% | 1.5% | ||
| Q2 24 | -22.1% | -44.7% | ||
| Q1 24 | 3.3% | -51.4% |
资本支出强度NOTESGHT
| Q4 25 | 7.4% | 0.8% | ||
| Q3 25 | 9.3% | 0.9% | ||
| Q2 25 | 6.4% | 1.1% | ||
| Q1 25 | 7.2% | 0.0% | ||
| Q4 24 | 6.8% | 0.7% | ||
| Q3 24 | 8.3% | 0.3% | ||
| Q2 24 | 9.4% | 0.4% | ||
| Q1 24 | 5.3% | 0.6% |
现金转化率NOTESGHT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.05× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NOTE
| Subscription | $21.2M | 95% |
| Advisory Advertising And Other | $1.0M | 5% |
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
